Institutional Ownership
Alx Oncology Hldgs Inc
CUSIP 00166B105COMALXOQ1 2026
13D / 13G Filings
39
Schedule 13D/13G on record
Beneficial Filers
19
Distinct reporting persons
Largest Stake
15.0%
Max % of class reported
Institutional Holders
65
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
39 filings · latest Feb 9, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Feb 9, 2026 | Ra Capital Management, L.P. | 13G | 9.9% | 13.12M | SEC |
| 2 | Feb 6, 2026 | Tcg Crossover Gp II, LLC | 13G | 11.0% | 13.01M | SEC |
| 3 | Feb 4, 2026 | Venbio Global Strategic Fund, L.P. | 13D/A | 10.0% | — | SEC |
| 4 | Nov 14, 2025 | Tang Capital Management, LLC | 13G/A | — | — | SEC |
| 5 | Nov 14, 2025 | Tang Capital Management, LLC | 13G/A | — | — | SEC |
| 6 | Oct 22, 2025 | Integrated Core Strategies (Us) LLC | 13G/A | 11.0% | 3.19M | SEC |
| 7 | Oct 8, 2025 | Millennium Management LLC | 13G | 11.0% | 2.71M | SEC |
| 8 | Aug 14, 2025 | Redmile Group, LLC | 13G/A | 8.5% | 4.64M | SEC |
| 9 | May 15, 2025 | Tang Capital Management, LLC | 13G/A | 5.9% | 3.16M | SEC |
| 10 | May 15, 2025 | Hbm Healthcare Investments (Cayman) Ltd. | 13G/A | 8.4% | 4.50M | SEC |
29 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Alx Oncology Hldgs Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Ra Capital Management, L.P. | 13.01M | $26.09M |
| 2 | Tcg Crossover Management, LLC | 13.01M | $26.09M |
| 3 | Venbio Partners LLC | 12.88M | $25.83M |
| 4 | Redmile Group, LLC | 7.96M | $15.97M |
| 5 | Blackstone Inc. | 5.83M | $11.71M |
| 6 | Driehaus Capital Management LLC | 5.73M | $11.50M |
| 7 | Marshall Wace, LLP | 3.76M | $7.51M |
| 8 | Vivo Capital, LLC | 3.18M | $6.39M |
| 9 | Almitas Capital LLC | 3.17M | $6.36M |
| 10 | 5am Venture Management, LLC | 3.06M | $6.13M |